Patient demographics
Patient . | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . |
---|---|---|---|---|---|---|
Sex | Male | Female | Female | Male | Male | Male |
Variant | E525K | E1021K | E1021K | E1021K | E1021K | E1021K |
Age of onset∗/enrollment into extension/current, y | 0.5/18/24 | 2/25/31 | 2/18/23 | 6/21/27 | 0.5/26/32 | 0.5/32/39 |
Leniolisib exposure, y | 6 | 6 | 5 | 6 | 6 | 6 |
Patient . | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . |
---|---|---|---|---|---|---|
Sex | Male | Female | Female | Male | Male | Male |
Variant | E525K | E1021K | E1021K | E1021K | E1021K | E1021K |
Age of onset∗/enrollment into extension/current, y | 0.5/18/24 | 2/25/31 | 2/18/23 | 6/21/27 | 0.5/26/32 | 0.5/32/39 |
Leniolisib exposure, y | 6 | 6 | 5 | 6 | 6 | 6 |
Age of onset is the onset of symptoms due to hypogammaglobulinemia.